Sign In
Buy ATAI
$4.53
-0.280 (-5.82%)
At Close: Jun 03, 2026
Cathie Wood Finds Elon Musk's Comment On Psychedelics, Ketamine An 'Interesting Thesis' For This Stock
10:01am, Monday, 02'nd May 2022 Benzinga
Popular stock picker Cathie Wood said on Sunday she finds Tesla Inc (NASDAQ: TSLA) CEO Elon Musk’s comments on the effectiveness of psychedelics and other plant-based substances as treatments for me
10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?
04:56pm, Thursday, 28'th Apr 2022 PennyStocks
Are these Cathie Wood penny stocks a buy right now?
The post 10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?
12:56pm, Thursday, 28'th Apr 2022
Are these Cathie Wood penny stocks a buy right now? The post 10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?
Shark Tank's Kevin O'Leary Says Twitter's Biggest Risk Is If Elon Musk 'Goes Away'
03:32am, Monday, 25'th Apr 2022 Benzinga
Shark Tank investor Kevin O’Leary hopes that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk will be successful in his attempt to take over Twitter (NYSE: TWTR) given the platform’s “failure”
atai Life Sciences ist Teilnehmer der im April stattfindenden Investorenkonferenz
04:04pm, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen für den klinischen Bereich, das sich der Aufgabe verschrieben h
atai Life Sciences to Participate in Upcoming April Investor Conference
04:26pm, Tuesday, 19'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disord
EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments
04:05pm, Tuesday, 19'th Apr 2022 Benzinga
For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging mark
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge
02:00pm, Tuesday, 19'th Apr 2022 Benzinga
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.
atai Life Sciences to Participate in Upcoming April Investor Conference
12:26pm, Tuesday, 19'th Apr 2022
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorder
Interested in Investing in Psychedelics? Check Out This Podcast.
12:07pm, Tuesday, 19'th Apr 2022 The Motley Fool
And other market news.
Interested in Investing in Psychedelics? Check Out This Podcast.
08:07am, Tuesday, 19'th Apr 2022
And other market news.
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
01:42pm, Monday, 04'th Apr 2022 Benzinga
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets.
In recent months, psychedelics stocks entered in
atai Life Sciences N.V. (ATAI) CEO Florian Brand on Q4 2021 Results - Earnings Call Transcript
04:05pm, Wednesday, 30'th Mar 2022
atai Life Sciences N.V. (ATAI) CEO Florian Brand on Q4 2021 Results - Earnings Call Transcript
atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update
06:59am, Wednesday, 23'rd Mar 2022
NEW YORK and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental heal
atai Life Sciences to Participate in Upcoming March Investor Conferences
05:08pm, Monday, 21'st Mar 2022 GlobeNewswire Inc.
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disord
